News

Get to know what's happening behind the scenes.

Learn more

Featured

Blog

Read the latest on our blog. Let's Talk Innovation.

Social

Stay connected with us on social media.

twitter_logo_20px.jpg @JNJinnovation

Events

Pages

Press Releases

Read our latest news.

  • Johnson & Johnson Announces Completion of Novira Therapeutics, Inc. Acquisition

    New Brunswick, NJ
    December 4, 2015

    Johnson & Johnson (NYSE: JNJ) today announced the completion of the acquisition of Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing innovative therapies for curative treatment of chronic hepatitis B virus (HBV) infection. The transaction was originally announced on November 4, 2015. Financial terms of the transaction have not been disclosed.

     

  • Collaborating to Study New Treatment for Insomnia Related to Depression

    London
    February 3, 2015

    One of the promising scientific collaborations in our neuroscience pipeline is with Minerva Neurosciences, focusing on MIN-202 – a selective orexin-2 antagonist being studied for the treatment of insomnia and potentially other disorders associated with sleep disorders such as major depressive disorder, an area of strategic focus for Janssen.

Pages

Accelerators

Close
Neomed (Montreal)
7171 Frederick-Banting
Montreal, Quebec, CANADA H4S 1Z9
(514) 367 1212
mail@www.neomed.ca
www.neomed.ca
Your web browser is out of date. For the most optimal experience, please upgrade to the newest version of IE. Thank You.